Current Opinion in Virology

Papers
(The TQCC of Current Opinion in Virology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Structure of SARS-CoV-2 spike protein117
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19110
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection97
Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles70
Recent advances in antiviral drug development towards dengue virus69
Future considerations for the mRNA-lipid nanoparticle vaccine platform60
Zoonotic disease and virome diversity in bats57
Current challenges to virus discovery by meta-transcriptomics56
Structure and function of SARS-CoV-2 polymerase49
Coronavirus entry: how we arrived at SARS-CoV-249
Global overview and major challenges of host prediction methods for uncultivated phages49
Animal models for SARS-CoV-249
Dengue vaccine development by the year 2020: challenges and prospects47
The healthy human virome: from virus–host symbiosis to disease43
A new generation of vaccines based on alphavirus self-amplifying RNA43
An update on salicylic acid biosynthesis, its induction and potential exploitation by plant viruses42
The virome of vector mosquitoes42
Protective and enhancing interactions among dengue viruses 1-4 and Zika virus41
A structural view of the SARS-CoV-2 virus and its assembly41
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing40
A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination39
Cell-to-cell movement of plant viruses via plasmodesmata: a current perspective on potyviruses38
COVID-19, the first pandemic in the post-genomic era38
Recent advances in understanding plant antiviral RNAi and viral suppressors of RNAi38
Engineering therapeutic phages for enhanced antibacterial efficacy36
Structure, function and assembly of the long, flexible tail of siphophages33
Viral Z-RNA triggers ZBP1-dependent cell death33
Dengue mouse models for evaluating pathogenesis and countermeasures32
Anti-viral protective capacity of tissue resident memory T cells32
Perspective on taxonomic classification of uncultivated viruses31
Host cell-intrinsic innate immune recognition of SARS-CoV-231
Salicylic acid: transport and long-distance immune signaling31
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?31
European regulatory aspects of phage therapy: magistral phage preparations30
Risk factors and biomarkers of severe dengue30
Measles virus persistence and its consequences29
Influenza D virus29
Tombusviruses orchestrate the host endomembrane system to create elaborate membranous replication organelles29
Detection of viruses by inflammasomes29
Structure, dynamics and phase separation of measles virus RNA replication machinery28
Entry of influenza A virus into host cells — recent progress and remaining challenges28
Viral structural proteins as targets for antivirals27
Current view and perspectives in viroid replication26
Natural killer cells and unconventional T cells in COVID-1926
Adenovirus – a blueprint for gene delivery25
Rotavirus cell entry: not so simple after all25
Progress and pitfalls of a year of drug repurposing screens against COVID-1925
Extracellular vesicles in virus infection and pathogenesis24
Mitigation of evolved bacterial resistance to phage therapy24
Measles virus in cancer therapy23
Animal morbilliviruses and their cross-species transmission potential23
Drug resistance mutations in HIV: new bioinformatics approaches and challenges23
Critical view on RNA silencing-mediated virus resistance using exogenously applied RNA22
Mapping the diverse structural landscape of the flavivirus antibody repertoire22
Hepatitis B virus–host interactions and novel targets for viral cure22
Proteases and variants: context matters for SARS-CoV-2 entry assays22
Immune system control of hepatitis C virus infection21
Principles of epithelial homeostasis control during persistent human papillomavirus infection and its deregulation at the cervical transformation zone21
Phage banks as potential tools to rapidly and cost-effectively manage antimicrobial resistance in the developing world21
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy21
Animal models of SARS-CoV-2 transmission21
Epigenetic control of the Epstein-Barr lifecycle20
Nucleic acid-mediated PAMP-triggered immunity in plants20
Molecular dynamics of the viral life cycle: progress and prospects20
Measles Resurgence and Drug Development20
Targeting of viral RNAs by Upf1-mediated RNA decay pathways19
Digital phagograms: predicting phage infectivity through a multilayer machine learning approach19
Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV00519
Phage therapy for secondary bacterial infections with COVID-1919
Measles pathogenesis, immune suppression and animal models19
Development of plant-made monoclonal antibodies against viral infections19
Rapid diagnostic tests to address challenges for global measles surveillance19
Cytomegalovirus as an immunomodulator across the lifespan19
UPR signaling at the nexus of plant viral, bacterial, and fungal defenses18
R gene mediated defense against viruses18
Revisiting an old friend: new findings in alphavirus structure and assembly18
Evolution of the interferon response: lessons from ISGs of diverse mammals17
Measles immunity and immunosuppression17
Remdesivir for the treatment of Covid-19: the value of biochemical studies17
Unresolved questions in the zoonotic transmission of MERS17
Broadly neutralizing antibodies against HIV-1 and concepts for application17
Tissues: the unexplored frontier of antibody mediated immunity17
The gut virome in inflammatory bowel diseases17
The long and winding road: human papillomavirus entry and subcellular trafficking17
Rhabdoviruses as vectors for vaccines and therapeutics17
Assembly of the virome in newborn human infants17
0.019413948059082